Health KarXT Schizophrenia Win; CBD for Anxiety; No Nuplazid for Alzheimer’s Psychosis Eli Pacheco Aug 11, 2022 0 The phase III EMERGENT-2 trial met its primary endpoint achieving a significant reduction in…
Health FDA Advisers Reject Nuplazid for Alzheimer’s Disease Psychosis Eli Pacheco Jun 18, 2022 0 An FDA advisory panel rejected pimavanserin (Nuplazid) for the treatment of hallucinations and…
Health Nuplazid to Make Its Case as Alzheimer’s Psychosis Drug to FDA Panel Eli Pacheco Jun 17, 2022 0 An FDA advisory committee will seek to determine whether the atypical antipsychotic pimavanserin…